Human Neuron Specific Enolase

Added to your cart

Human Neuron Specific Enolase

Cart subtotal: £0.00

View cart (0) Checkout

#SKU P147-3

£121.47

Price excludes shipping costs.
To view our shipping costs click here.

Need to order this product in bulk?

Contact our team of experts to discuss your bulk requirements

Contact our expert team

Product Details

This gamma enolase is a glycolytic enzyme present in brain and neuroendocrine tissue. It is a dimer with subunits of molecular weight of 45 kDa. NSE is used to monitor tumour bulk and provides useful information in terms of metastatic activity. It is also used to monitor brain injuries, in conjunction with another brain protein, S100 Beta.
0.1mg
P147-3

More information

Attributes

Description

  • Shipping Information
  • Dry Ice
  • Abbreviations
  • NSE
  • Specification
  • >96%
  • Recommended Use
  • Research and further manufacturing
  • Storage
  • Below -15°C
  • Buffer
  • 0.01M NaH2PO4 buffer pH 7.4 containing 0.15M NaCl and 0.005M MgSO4
  • Presentation Matrix
  • 0.01M NaH2PO4 buffer pH 7.4 containing 0.15M NaCl and 0.005M MgSO4
  • Purity/grade
  • >96%
  • Source
  • Brain Tissue
  • Applications
  • Biosensors, Clinical Chemistry, Control Manufacture, ELISA, Lateral Flow, Life Science
  • Molecular weight
  • 45kDa

Technical Documents

Certificates Of Analysis (77.33KB)

Safety Data Sheet (39KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox